期刊文献+

经尿道膀胱肿瘤二次电切术的临床意义 被引量:3

下载PDF
导出
摘要 在我国,膀胱癌为泌尿外科最常见的肿瘤,首次发现时约70%~80%为非肌层浸润性,其预后相对较好,5年生存率达40%-80%。据统计经尿道膀胱肿瘤电切术(TURBT)术后肿瘤复发率15%~75%。T1G3期膀胱癌具有可变性和不可预测的生物潜能,虽然属于非肌浸润性膀胱癌.但其生物学行为类似于肌层浸润性膀胱癌。首次电切可能有癌细胞残留.特别是多发性肿瘤,即使联合膀胱灌注化疗,早期复发、分期进展的风险很大。
出处 《中国药物与临床》 CAS 2013年第7期925-927,共3页 Chinese Remedies & Clinics
  • 相关文献

参考文献7

  • 1Pakin DM,Bray F,Ferlay J,et al. Global cancer statistics, 2002. CA Cancer J Clin, 2005,55 : 74-108.
  • 2Witjes JA,Douglass J. The role of hexaminolevulinate fluores- cence cystoseopy in bladder cancer. Nat Clin Praet Urol,2007, 4 : 542-549.
  • 3Borkowski A. Superficial bladder cancer T1G3: the choice of treatment. BJU Int, 2002,89 (6) : 623-627.
  • 4那彦群,叶章群,孙光,等.中国泌尿外科疾病诊疗指南.北京:人民卫生出版社,2011:17-48.
  • 5Babjuk M,Oosterlinck W,Sylvester R,et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder. Eur Urol, 2008,54: 303-314.
  • 6Divrik RT,Sahin AF,Yildirim U,et al. Impact of routine second transurethral resection on the long-term outcome of patients with newly diagnosed pT1 urothelial carcinoma with respect to recur-rence, progression rate, and disease-specific survival:a prospec- tive randomised clinical trial. Eur Urol,2010,58(2) : 185-190.
  • 7Zukkirchen MA,Sulser T, Gaspert A,et al. Second transurethral resection of superficial transitional cell carcinoma of the bladder: a must even for .experienced urologists. Urol Int,2004,72:99- 102.

同被引文献27

  • 1Herr HW,Donat SM,Dalbagni G. Can restaging transurethral resection of T1 bladder cancer select patients for immediate cystectomy[J].{H}Journal Of Urology,2007,(01):75-79.
  • 2Dalbagni G,Vora K,Kaag M. Clinical out come in a contemporary series of restaged patients with clinical T1 bladder cancer[J].{H}EUROPEAN UROLOGY,2009,(06):903-910.
  • 3Dutta SC,Smith JAJr,Shappell SB. Clinical understaging of high risk nonmuscle invasive urothelial carcinoma treated with radical cystectomy[J].{H}Journal Of Urology,2001,(02):490-493.
  • 4Divrik RT,Yildirim U,Zorlu F. The effect of repeat transurethral resection on recurrence and progression rates in patients with T1 tumors of the bladder who received intravesical mitomycin:a prospective,randomized clinical trial[J].{H}Journal Of Urology,2006,(05):1641-1644.
  • 5Babjum, Ostedine W, Sylvesterr, et al. EAU guidelines on non- muscle - invasive umthelial carcinoma Of the bladder [J]. Enr Urol,2011,59:997 - 1 008.
  • 6Msriappan P, Zaehou A, Grigor K . Detrusor muscle in the first, apparently complete transnrethral resection of bladder tu- mourspecimen is a surrogate marker of resection quality, pre- dicts risk of early recurrence, and is dependent on operator ex- perience[ J]. Eur Urol,2010,57:843 - 849.
  • 7陈兴屹,温机灵,陈卫华,温晓飞,杨波,王跃闽.高危非肌层浸润性膀胱癌二次经尿道电切治疗体会[J].同济大学学报(医学版),2011,32(1):89-91. 被引量:16
  • 8许晓文,沈志杰,徐耀庭,李杜渐,黄汝强,顾伟平,顾炜,谢敏.非肌层浸润膀胱癌术后再电切的临床意义[J].中国内镜杂志,2011,17(3):271-272. 被引量:2
  • 9王少玲,符始艳,周家仪,黄金月.慢性阻塞性肺疾病患者的延续护理[J].中华护理杂志,2011,46(8):758-760. 被引量:137
  • 10李成龙,祝恒成.二次电切对T_1G_3期膀胱肿瘤疗效影响的回顾性分析[J].临床泌尿外科杂志,2011,26(10):745-746. 被引量:13

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部